SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C

Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy

Avidan U. Neumann, Nancy P. Lam, Harel Dahari et al. · Science · 1998 · 2.1K citations

Pharmacy, Infectious Diseases, Pharmacokinetics +17

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

Hiroaki Okamoto, Yuichi Sugiyama, S Okada et al. · Journal of General Virology · 1992 · 1.3K citations

Life Sciences, Infectious Diseases, Microbiology +13

Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity

Samy Ashkar, Georg F. Weber, Marie Sanchirico et al. · Science · 2000 · 1.1K citations

Life Sciences, Immunology, Pathology +17

Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan

Haruhiko Yoshida, Yasushi Shiratori, Mitsuhiko Moriyama et al. · Annals of Internal Medicine · 1999 · 1.1K citations

Medicine, Oncology, Cancer Control +16

Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190 562 genetic variations in the human genome

Hiroaki Haga, Ryo Yamada, Yoshifumi Ohnishi et al. · Journal of Human Genetics · 2002 · 304 citations

Life Sciences, Genetics, Molecular Genetics +11